Goldenberg DM - Search Results

1

The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target.

Goldenberg DM, Stein R, Sharkey RM. Goldenberg DM, et al. Oncotarget. 2018 Jun 22;9(48):28989-29006. doi: 10.18632/oncotarget.25615. eCollection 2018 Jun 22. Oncotarget. 2018. PMID: 29989029 Free PMC article. Review.

2

Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC).

Goldenberg DM, Cardillo TM, Govindan SV, Rossi EA, Sharkey RM. Goldenberg DM, et al. Oncotarget. 2015 Sep 8;6(26):22496-512. doi: 10.18632/oncotarget.4318. Oncotarget. 2015. PMID: 26101915 Free PMC article.

3

Correction: Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC).

Goldenberg DM, Cardillo TM, Govindan SV, Rossi EA, Sharkey RM. Goldenberg DM, et al. Oncotarget. 2020 Mar 10;11(10):942. doi: 10.18632/oncotarget.27512. eCollection 2020 Mar 10. Oncotarget. 2020. PMID: 32206190 Free PMC article.

4

Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer.

Cardillo TM, Rossi DL, Zalath MB, Liu D, Arrojo R, Sharkey RM, Chang CH, Goldenberg DM. Cardillo TM, et al. Among authors: goldenberg dm. Oncotarget. 2020 Oct 27;11(43):3849-3862. doi: 10.18632/oncotarget.27766. eCollection 2020 Oct 27. Oncotarget. 2020. PMID: 33196706 Free PMC article.

5

A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy.

Stein R, Goldenberg DM. Stein R, et al. Among authors: goldenberg dm. Mol Cancer Ther. 2004 Dec;3(12):1559-64. Mol Cancer Ther. 2004. PMID: 15634649

6

Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy.

Goldenberg DM, Sharkey RM, Paganelli G, Barbet J, Chatal JF. Goldenberg DM, et al. J Clin Oncol. 2006 Feb 10;24(5):823-34. doi: 10.1200/JCO.2005.03.8471. Epub 2005 Dec 27. J Clin Oncol. 2006. PMID: 16380412 Review.

7

Targeted therapy of cancer: new prospects for antibodies and immunoconjugates.

Sharkey RM, Goldenberg DM. Sharkey RM, et al. Among authors: goldenberg dm. CA Cancer J Clin. 2006 Jul-Aug;56(4):226-43. doi: 10.3322/canjclin.56.4.226. CA Cancer J Clin. 2006. PMID: 16870998 Free article. Review.

8

CD74: a new candidate target for the immunotherapy of B-cell neoplasms.

Stein R, Mattes MJ, Cardillo TM, Hansen HJ, Chang CH, Burton J, Govindan S, Goldenberg DM. Stein R, et al. Among authors: goldenberg dm. Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5556s-5563s. doi: 10.1158/1078-0432.CCR-07-1167. Clin Cancer Res. 2007. PMID: 17875789 Review.

9

Novel radioimmunopharmaceuticals for cancer imaging and therapy.

Sharkey RM, Goldenberg DM. Sharkey RM, et al. Among authors: goldenberg dm. Curr Opin Investig Drugs. 2008 Dec;9(12):1302-16. Curr Opin Investig Drugs. 2008. PMID: 19037837 Review.

10

Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy.

Sharkey RM, Rossi EA, McBride WJ, Chang CH, Goldenberg DM. Sharkey RM, et al. Among authors: goldenberg dm. Semin Nucl Med. 2010 May;40(3):190-203. doi: 10.1053/j.semnuclmed.2009.12.002. Semin Nucl Med. 2010. PMID: 20350628 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

750 results

Search Page

Filters